Trithorax-group proteins and their mammalian homologs, including those in BAF (mSWI/SNF) complexes, are known to oppose the activity of Polycomb repressive complexes (PRCs) 1-5 . This opposition underlies the tumor-suppressive role of BAF subunits 3,5-7 and is expected to contribute to neurodevelopmental disorders 8, 9 . However, the mechanisms underlying opposition to Polycomb silencing are poorly understood. Here we report that recurrent disease-associated mutations in BAF subunits induce genome-wide increases in PRC deposition and activity. We show that point mutations in SMARCA4 (also known as BRG1) mapping to the ATPase domain cause loss of direct binding between BAF and PRC1 that occurs independently of chromatin. Release of this direct interaction is ATP dependent, consistent with a transient eviction mechanism. Using a new chemical-induced proximity assay, we find that BAF directly evicts Polycomb factors within minutes of its occupancy, thereby establishing a new mechanism for the widespread BAF-PRC opposition underlying development and disease.
Trithorax-group proteins and their mammalian homologs, including those in BAF (mSWI/SNF) complexes, are known to oppose the activity of Polycomb repressive complexes (PRCs) [1] [2] [3] [4] [5] . This opposition underlies the tumor-suppressive role of BAF subunits 3,5-7 and is expected to contribute to neurodevelopmental disorders 8, 9 . However, the mechanisms underlying opposition to Polycomb silencing are poorly understood. Here we report that recurrent disease-associated mutations in BAF subunits induce genome-wide increases in PRC deposition and activity. We show that point mutations in SMARCA4 (also known as BRG1) mapping to the ATPase domain cause loss of direct binding between BAF and PRC1 that occurs independently of chromatin. Release of this direct interaction is ATP dependent, consistent with a transient eviction mechanism. Using a new chemical-induced proximity assay, we find that BAF directly evicts Polycomb factors within minutes of its occupancy, thereby establishing a new mechanism for the widespread BAF-PRC opposition underlying development and disease.
In vertebrates and invertebrates, Polycomb complexes are associated with chromatin containing repressive marks that is silent or weakly transcribed. Polycomb-mediated silencing is critical to development [10] [11] [12] [13] [14] , and aberrant repressive activity can promote malignancy in several cancers [15] [16] [17] [18] . BAF complexes oppose Polycomb silencing, and disruption of the balance between BAF and Polycomb underlies oncogenic transformation in two cancer models 3, 5, 6 . Furthermore, BAF-inactivating mutations have been found in independent screens for driver mutations in renal 19 , ovarian 20 , medulloblastoma 21 , rhabdoid 22 , colorectal 23 , and lung 24 tumors, as well as in pan-cancer studies 7, 25 , suggesting that disrupted opposition to Polycomb silencing may be a general feature of common cancers. Additionally, a large number of tumor samples and patients affected by neurological disorders carry heterozygous mutations of the BAF ATPase SMARCA4 or SMARCA2 (ref. 26) , and CRISPR/Cas9 tiling screens in cancer cell lines indicate that the ATPase domain is the most functionally important domain of SMARCA4 (ref. 27 ). Thus, we hypothesized that the SMARCA4 ATPase domain has a central role in the opposition to Polycomb silencing.
To investigate the effects of SMARCA4 inactivation, we began by identifying the acute effects of SMARCA4 deletion on PRC1 and PRC2 using a conditional knockout line of mouse embryonic stem cells (mESCs). After conditional deletion of Smarca4, ChIP-seq analysis of RING1B (a dedicated catalytic subunit of PRC1) showed reproducible increased PRC1 occupancy at ~34% (1,634/4,754) of PRC1 sites over the genome (Fig. 1a,e and Supplementary Figs. 1 and 2), although RING1B expression levels did not change ( Supplementary  Fig. 3 ). Sites of increased occupancy were distributed across several defined classes 28 of Polycomb target genes, as well as genes not typically targeted by Polycomb in wild-type cells (Supplementary Fig. 1 ). Developmental regulators were among the most highly enriched gene sets corresponding to sites with increased RING1B occupancy (Supplementary Fig. 1 ). We obtained similar results for ChIP-seq analysis of SUZ12, a dedicated subunit of PRC2, with ~36% (1,892/5,279) of sites showing increased PRC2 occupancy (Fig. 1b,e) . We sought to compare the magnitude of this effect to that of conditional deletion of ARID1A, another essential BAF subunit commonly inactivated in cancer (Fig. 1c,d ). Conditional deletion of Arid1a similarly caused increased RING1B and SUZ12 peaks, but at substantially fewer loci; these loci were largely a subset of those at which PRC occupancy was increased after SMARCA4 deletion (Fig. 1f) . Previous ChIP-seq studies of trimethylation of histone H3 at lysine 27 (H3K27me3) after SMARCA4 deletion showed less dramatic effects 4 , which we attribute to the slow rate of H3K27me3 accumulation. The high degree of correlation between the PRC1 and PRC2 changes induced by BAF subunit deletion across the genome (Fig. 1f) indicates that there are characteristic, subunit-dependent changes in Polycomb occupancy after BAF inactivation. Using RNA-seq analysis, we confirmed that genes with increased PRC1 and PRC2 occupancy after SMARCA4 deletion showed reduced expression, indicating that the changes we observed were sufficient to alter gene expression (Fig. 1g-i) .
In many human malignancies, deleterious missense mutations occur more frequently in SMARCA4 than truncating mutations (Fig. 2a) , suggesting that functional inactivation rather than loss of expression Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin is positively selected in cancer. SMARCA4 is a member of the SF2 helicase-like family of ATPases 29 , and mutation counts in primary tumors and cancer cell lines compiled from The Cancer Genome Atlas (TCGA) 30 and the Cancer Cell Line Encyclopedia (CCLE) 31 show clusters of mutations at or near conserved SF2 motifs, including the Walker A (ATP-binding) and Walker B (hydrolysis) motifs and the intervening linker region that contains the conserved SF2 helicase (putative substrate-binding) motif, motif 1A (Fig. 2b) 32 . Figure 1 Characteristic accumulation of PRC1 and PRC2 after BAF subunit deletion. (a) Genome-wide increases in PRC1 occupancy as determined by RING1B ChIP-seq in conditional Smarca4 knockout mESCs. Each point on the plot represents an individual RING1B peak. Sites that are increased (orange) or decreased (blue) or that remain unchanged (gray) are labeled according to the criteria in the Online Methods. WT, wild type; KO, knockout. Correlation and P values were obtained from Pearson's product-moment correlation tests; pFDR, false-discovery-rate-adjusted P value. l e t t e r s l e t t e r s As many cancer-related mutations of SMARCA4 are heterozygous, we sought to investigate whether missense mutations mapping to the ATPase domain would result in deregulation of Polycomb silencing even when the mutant protein was coexpressed with wildtype SMARCA4. Using a conditional Smarca4 knockout mESC line 4 , we rescued SMARCA4 deletion with lentiviral expression of wild-type SMARCA4-GFP fusion and either wild-type or mutant SMARCA4 tagged with V5 (SMARCA4-V5), resulting in expression levels of SMARCA4 equivalent to those of endogenous protein (Supplementary Fig. 3 ). This strategy allowed us to observe the effects of mutation in a setting that mimics heterozygous mutation and permitted us to separately identify two SMARCA4 variants in the same line. On the basis of mutation frequencies in cancer and neurodevelopmental disorders 9 , we focused on six alterations, examining p.Gly784Glu, p.Lys785Arg, p.Tyr860His, p.Glu861Lys, p.Glu882Lys, and p.Arg885His (residues numbered according to the human protein product; UniProt, P51532). Of these, p.Lys785Arg has previously been characterized as a bona fide ATPase-inactivating alteration 33, 34 . These alterations map to three conserved regions of the N-terminal ATPase domain: Walker A, Walker B, and the intervening linker. Notably, the N-terminal ATPase domain where these mutations map is 100% identical in mice and humans. Hence, we coexpressed each of the corresponding mutants as a SMARCA4-V5 fusion, alongside wild-type SMARCA4-GFP, both as mouse proteins in mESCs. As a control, we compared the results for these cells to those for similarly prepared cells expressing wild-type SMARCA4-V5 instead of a mutant.
In comparison to expression of wild-type SMARCA4 alone, heterozygous expression of each SMARCA4 ATPase mutant resulted in increased PRC1 occupancy at specific genes, including developmental regulators such as Fgf11 (Supplementary Fig. 4 ). Among all PRC1 sites over the genome, sites with increased PRC1 occupancy upon either SMARCA4 ATPase alteration or SMARCA4 deletion were significantly overlapping (P = 1 × 10 −30 ; Supplementary Fig. 5 ). Patterns of change in PRC1 occupancy were highly correlated and reproducible across all mutants and were uncorrelated with the variation between wild-type replicates (Fig. 2c−e) . In comparison to unchanged sites, sites with increased PRC1 occupancy induced by expression of the SMARCA4 ATPase mutants were enriched in promoters, transcription start sites (TSSs), and CpG islands but were depleted in 3′ UTRs and intergenic regions (Fig. 2f) . To confirm that this effect was not unique to mouse cells, we examined genome-wide RING1B occupancy in the human lung cancer cell line A549, which harbors a null mutation of SMARCA4; upon expression of the same wild-type or ATPase-mutant mouse SMARCA4 proteins, we observed similar genome-wide effects (Supplementary Fig. 6 ).
We sought to determine whether specific genomic marks were predictive of changes in PRC1 occupancy upon expression of SMARCA4 mutants. Thus, we examined ChIP-seq data for 111 factors previously obtained from wild-type mESCs. Rank ordering showed that several permissive marks, notably trimethylation of histone H3 at lysine 4 (H3K4me3), had elevated read densities at sites predisposed to increased PRC1 occupancy in the presence of SMARCA4 ATPase mutants (Supplementary Fig. 7 ). We used Fisher's linear discriminant 35, 36 to identify the combinations of features that optimally distinguish sites with increased PRC1 occupancy from those with decreased PRC1 occupancy. We found that, indeed, H3K4me3 and several other features associated with active promoters, including occupancy by the H3K4 methyltransferase KMT2B 37 and the l e t t e r s H3K4 demethylase KDM5A, as well as acetylation of histone H3 at lysine 27 (H3K27ac) and occupancy by HDAC1 and HDAC2, were enriched at sites with increased PRC1 occupancy and depleted from sites with decreased occupancy. Remarkably, these and other features completely distinguish the two classes of sites along the chromatin landscape ( Fig. 3a) . Lasso multivariate regression 38 independently confirmed that H3K4me3 is the mark most positively associated with sites showing increased RING1B occupancy induced by SMARCA4 ATPase mutants (Fig. 3b) . Indeed, across bivalent sites, the changes in RING1B occupancy caused by ATPase mutants were much better predicted by the levels of H3K4me3 than they were by H3K27me3 levels in wild-type cells (Supplementary Fig. 7) . Together, our results indicate that CpG-rich bivalent promoters with the highest levels of permissive marks, particularly H3K4me3, are those most sensitive to SMARCA4 ATPase mutants. This observation suggests that these two Trithorax-group complexes (BAF and MLL-containing COMPASS complexes) work in concert. Because PRC1 contributes to recruitment of PRC2 (ref. 39) , we reasoned that expression of the mutants could also lead to increased levels of H3K27me3, a mark reflecting PRC2 activity, at sites where PRC1 occupancy increased. Therefore, we performed ChIP-seq analysis for H3K27me3 on the same ATPase-mutant cell lines described above. We observed consistent increases in H3K27me3 levels across the genome (Fig. 4a-d) . H3K27me3 changes were highly correlated across the set of mutants and were uncorrelated with changes between wild-type replicates (Fig. 4c,d) . Although the changes were correlated for all mutants (including the ATPase-dead mutant Lys785Arg; Supplementary  Fig. 8 ), we focused on Glu861Lys as an example. Elevated H3K27me3 levels were frequently located immediately adjacent to sites with increased RING1B occupancy (Fig. 4a) . We examined all H3K27me3 peaks that occurred within ±3 kb of a CpG island and found that these sites consistently showed increased RING1B occupancy in the flanking CpG island, ~2 kb from the peak with increased H3K27me3 (Fig. 4e) . Furthermore, we classified PRC1 sites into those with decreased, unchanged, or increased occupancy and plotted the mean profiles of both H3K27me3 and H3K4me3 within each category (Fig. 4f) . At sites with increased PRC1 occupancy, we observed increased H3K27me3 levels in regions ~2 kb from the RING1B peaks. This effect was substantially diminished at unchanged sites, and we observed no change in H3K27me3 levels at sites where RING1B occupancy was decreased (Fig. 4f) . H3K4me3 levels were unaffected, indicating that the effects on H3K27me3 are unique and arise through the effects of Smarca4 mutations on Polycomb activity. Together, our results indicate that disease-associated SMARCA4 ATPase mutants permit accumulation of PRC1 at CpG-rich bivalent promoters, as well as increased activity of PRC2, with increased H3K27me3 marking ~2 kb away from the sites of increased PRC1 occupancy. The origin of this offset is not currently known, but this offset may reflect the footprints of Polycomb factors, topological changes, nucleosome depletion, or other unknown factors.
To examine the molecular mechanisms that underlie Polycomb opposition, we sought to ascertain whether there was a direct interaction between BAF and PRC1. In earlier mass spectrometry studies, our laboratory observed that RYBP, a subunit of variant PRC1 complexes, coimmunoprecipitated with SMARCA4 (Supplementary Table 1 in ref. 40) , suggesting a direct interaction between BAF and PRC1. We therefore performed immunoprecipitation experiments (Fig. 5a ) and found that SMARCA4 and SMARCC1 (BAF155), both core dedicated BAF subunits, coimmunoprecipitated with RYBP and RING1B at low but detectable levels (Fig. 5b) . Furthermore, this interaction was reciprocal, as immunoprecipitation of the core BAF subunit SMARCB1 (BAF47) showed an interaction with RYBP and RING1B (Fig. 5c) . This interaction occurred in the soluble nuclear fraction and was insensitive to DNase I treatment (Fig. 5d) , consistent with a direct interaction that does not require mediation through chromatin. Moreover, incubation with ATP induced the release of PRC1 from BAF (Fig. 5e ), but this release was impaired in the presence of ATP analogs that inhibit hydrolysis (Fig. 5f) . Taken together, our results indicate a direct interaction between BAF and PRC1 that is regulated by ATP hydrolysis. Similar results were obtained using CBX7, a dedicated subunit of canonical PRC1 (ref. 41) (Supplementary Fig. 9 ), indicating that SMARCA4 performs direct ATP-dependent regulation of both variant and canonical PRC1 complexes.
To examine how mutations of Smarca4 mapping to the ATPase domain affected this interaction, we selected from each class of mutants identified above the one with the strongest effect on RING1B occupancy: Gly784Glu (Walker A), Glu882Lys (Walker B), and Glu861Lys (linker region). We then repeated the immunoprecipitations of RING1B and RYBP in cells coexpressing wild-type SMARCA4-GFP and either wild-type or mutant SMARCA4-V5. Although wild-type and mutant SMARCA4 were expressed at nearly identical levels, we found that the ATPase mutants did not efficiently coimmunoprecipitate with RING1B and RYBP; instead, wild-type protein preferentially coimmunoprecipitated with these factors (Fig. 5g,h) . Hence, our results confirm that SMARCA4 ATPase activity regulates this direct interaction. The requirement of a functioning ATPase for both binding and release of PRC1 can be rationalized by considering that ATP hydrolysis l e t t e r s lowers the energy barrier between the bound state and the unbound state, therefore catalyzing both binding and release ( Supplementary  Fig. 10a ). An example of a possible mechanism might involve an ATPregulated latch (Supplementary Fig. 10b ).
Our coimmunoprecipitation results indicated that BAF regulates PRC1 by direct ATP-dependent interactions. Indeed, direct ATP-dependent interactions have been reported between Snf2-like remodelers and other protein factors, such as between MOT1 and its substrate TBP 42, 43 . However, it remained uncertain in cells whether the BAF-PRC1 interaction was limited to the soluble nucleoplasm or occurred directly on chromatin. To answer this question and to demonstrate that the interaction was functional, we adapted a strategy for chemical-induced proximity in living cells 44, 45 . We used genome editing to introduce an array of 12 zinc-finger-binding elements upstream of Ascl1, a bivalent gene decorated with PRC1 and PRC2 in its CpG island promoter. By expressing a fusion of FKBP to a zincfinger-binding domain anchor and a fusion of the FRB domain of mTOR to the BAF subunit SS18, we were able to use rapamycin to induce recruitment of BAF to the zinc-finger binding site (Fig. 6a) . After incubation with 30 nM rapamycin, ChIP-qPCR analysis showed recruitment of BAF (Fig. 6b) and loss of PRC1 and PRC2 (Fig. 6c,d) . Reduced levels of Polycomb factors were detectable within 5 min of rapamycin addition, and levels steadily decreased for up to 60 min. Reduction of PRC1 and PRC2 occupancy was specific to the Ascl1 locus and was not observed at the bivalent Hoxa3 control region (Fig. 6d) , allowing us to conclude that BAF directly ejects PRC1 on chromatin. Removal of PRC1 may contribute to reduction in PRC2 occupancy, as PRC1 is thought to lead to PRC2 placement 46 . Recruitment of LSH1, another Snf2-like remodeler, did not lead to removal of PRC1 or PRC2 at the Ascl1 locus, demonstrating that Polycomb eviction is not common to all Snf2-like remodelers (Supplementary Fig. 11) . A separate study reported by our laboratory shows that disruption of this direct eviction is a widespread consequence of BAF deregulation in cancer 45 . 
l e t t e r s
We conclude that both binding and release of PRC1 are regulated by ATP-dependent conformational states within BAF complexes. This direct regulation results in the local eviction of PRC1 from chromatin within minutes of BAF recruitment, further supporting a direct role. By failing to evict PRC1 from chromatin, SMARCA4 deletion and ATPase mutations permit accumulation of PRC1 and PRC2 in CpG island promoters across the genome, which may contribute to oncogenesis or epigenetic plasticity during tumor development. Furthermore, our results establish that BAF complexes have non-histone substrates, such as PRC1, which are direct targets of their ATPase activity. As a result, deregulation of Polycomb occupancy and activity may be more common in BAF-mutated cancers than has previously been recognized. Eviction of Polycomb factors from chromatin may also have a critical role in neural development, where neuron-specific nBAF complexes are essential for postmitotic neuronal function 47, 48 .
MeTHodS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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This paper is dedicated to the memory of Joseph P. Calarco, a great friend and passionate scientist. We apologize to our colleagues whose work we could not cite owing to space constraints. We thank G. Preparation of nuclear extracts. Cells were dissociated with trypsin and washed with PBS. Cells were then resuspended in Buffer A (25 mM HEPES pH 7.6, 5 mM MgCl 2 , 25 mM KCl, 0.05 mM EDTA, 10% glycerol, and 0.1% NP-40) supplemented with 1 mM DTT and Complete protease inhibitor cocktail (Roche) and were incubated on ice for 7 min. After centrifugation (1,000g), nuclei were resuspended in Buffer C (10 mM HEPES pH 7.6, 3 mM MgCl 2 , 100 mM KCl, 0.1 mM EDTA, and 10% glycerol) supplemented with 1 mM DTT and protease inhibitor cocktail (Roche), and ammonium sulfate was added to a final concentration of 300 mM. Nuclei were lysed at 4 °C with overhead rotation for 30 min, and soluble proteins were isolated from nuclear extracts via ultracentrifugation at 350,000g for 15 min. The supernatant was incubated on ice for 20 min with 0.3 mg/ml of ammonium sulfate and then subjected to ultracentrifugation at 350,000g for 15 min. The supernatant was discarded, and precipitated protein was used for immunoprecipitation and immunoblotting.
Immunoprecipitation. For individual immunoprecipitation reactions, the protein precipitate derived from nuclear extracts was resuspended in IP buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 0.1% NP-40) supplemented with 1 mM DTT and protease inhibitor cocktail (Roche), with or without 10 mM ATP, AMPPNP, or ATPγS. After Bradford assays, protein concentration was adjusted to 300 µg of protein lysate in 250 µl of IP buffer, and samples were incubated with 3 µg of antibody (Supplementary Table 1 ) for 12-16 h at 4 °C. Antibodies were immobilized with subsequent 4-h incubation with Protein A Dynabeads (Thermo Fisher), washed three times with 1 ml per wash of IP buffer at room temperature, and then resuspended in 12 µl of 2× loading buffer (LDS, Thermo Fisher) with 2-mercaptoethanol for subsequent immunoblot analysis. For experiments with DNase, 2 µg of plasmid reporter with or without 10 U of DNase I (Roche) was added to the 300-µl reaction volume. All antibodies used in this study are described in Supplementary Table 1 .
ChIP-seq library preparation. All libraries were independently prepared from separately cultured samples in duplicate, according to previously described protocols [51] [52] [53] . Size selection was performed by extracting 200-to 400-bp DNA fragments on a 2% agarose E-gel (Invitrogen) before PCR amplification, and fragments were then extracted using the RNeasy MinElute cleanup kits (Qiagen). PCR amplification was performed using ≤14 cycles, and the resulting DNA was quantified by Qubit fluorometric quantitation. Sequencing was performed using single-end reads on the Illumina HiSeq 2000 sequencer.
Processing of ChIP-seq data. Analysis of high-throughput sequencing data was not performed with blinding to sample identity, but the following techniques were applied uniformly to all data sets. Single-end ChIP-seq reads were processed by mapping to the mm9 reference mouse genome using Bowtie 1. All peaks from control and treatment data sets within ±1 kb were merged, and peaks below a threshold of 30 RPM (in at least one data set) were discarded to remove low-quality peak calls. For each data set, the total number of reads overlapping each of the resulting peaks was compared for differential peak calling. Differential peak calls were made using DESeq2 (ref. 56) , using the summed number of reads at all sites above the 95th percentile as size factors to avoid the influence of background ChIP-seq reads. DESeq2 accounts for individual site variances across all replicates to make differential peak calls. Log 2 -transformed fold changes were calculated by the default use of maximum a posteriori estimation using a zero-mean normal prior (Tikhonov-Ridge regularization). FDRcorrected P values were calculated using the Benjamini-Hochberg procedure. Differential calls were made by requiring fold changes of >1.5-fold in either direction and FDR-corrected P < 0.10. RPM values in genome tracks are the mean values across both replicates from each condition. Calculation of mean genome track densities was performed using bwtool 57 , and browser tracks were prepared using Gviz 58 . Mean density profiles were computed using bwtool by calculating the mean base-pair coverage across all replicates for a given condition, then calculating the mean coverage across all sites using a 6-kb window. Analysis of peak overlap was performed using BEDtools 59 .
RNA-seq library preparation. RNA was prepared by QIAzol extraction, followed by poly(dT) capture. mRNA was converted to DNA using previously described protocols 53 and then size selected for DNA fragments of 200-400 bp in length on a 2% agarose E-gel. Following PCR amplification (≤14 cycles) and Qubit fluorometric quantification, sequencing was performed using single-end reads on the Illumina HiSeq 2000 sequencer.
Processing of RNA-seq data. Reads within coding regions were counted using htseq 60 , with gene definitions obtained from the refGene table of RefSeq genes in the UCSC Table Browser . The table of all counts was processed using DESeq2, with default parameters. Log 2 -transformed fold changes were calculated using maximum a posteriori estimation with a zero-mean normal prior (Tikhonov-Ridge regularization). FDR-corrected P values were calculated using the Benjamini-Hochberg procedure. Differential calls were made by requiring fold changes of >1.5-fold in either direction and FDR-corrected P < 0.10.
Public data sets analyzed in this study. Read densities were obtained from publicly available data sets in the Gene Expression Omnibus (GEO) (Supplementary Table 2 ). For each of these chromatin feature data sets, read fragments were extended to 200 bp from the 3′ end and base-pair coverage was determined using BEDtools 59 .
Multivariate analyses of chromatin factors and marks. To rank order chromatin features, iterative bootstrap resampling of 100 samples was used to obtain the 99% confidence interval for the mean. Fisher's linear discriminant was used to assay combinations of features within qualitative site classes (increased, decreased, and unchanged), and Lasso regression was performed using the 'glmnet' package 38 in R to assay the direct contribution of each chromatin feature to the observed fold change at that site. For both analyses, the number of ChIP-seq reads within ±3 kb of peak centers was summed for each chromatin feature.
Genome annotation enrichment. Enrichment for overlap with genomic annotations was performed by comparing how frequently each peak fell into basic genomic annotations, separately determined for each class of differential peak call described above. Enriched GO terms and log-transformed enrichment of genomic annotation overlap were calculated for each class of site using HOMER 61 .
Residue mutation frequencies and conservation scores. Mutation frequencies were obtained by assembling all non-silent coding mutations to SMARCA4 from TCGA and CCLE. Mutation frequency values are presented using kernel density estimation to obtain an estimate of the true underlying mutation frequency. Residue conservation scores were obtained by generating and performing multiple-sequence alignment on 7,033 RefSeq and GenBank sequences with homology to amino acid residues 750-900 of SMARCA4, using FRpred 62 . This alignment was used to generate a residue conservation score based on Shannon entropy 63 , using a three-residue averaging window 64 .
Functional impact of mutations in TCGA data sets. Mutations present in TCGA data were analyzed for functional impact and assigned to one of four categories (truncating, deleterious missense, benign, or unknown) using PolyPhen-2 scores 65 , generated by Oncotator 66 . Truncating mutations include frameshift and nonsense mutations and may lead to nonsense-mediated decay; all other mutations are missense mutations that affect coding sequence but are otherwise expected to be fully expressed.
Densitometry and analysis. All densitometry of immunoblot bands was performed by calculating integrated band intensities with LiCor ImageStudio 5.2.5. To compare enrichment of SMARCA4-GFP and SMARCA4-V5, the intensity of each band following coimmunoprecipitation was measured and compared to the intensity in the input lane. Log 2 -transformed enrichment ratios arising from the coimmunoprecipitation were calculated using the following expression: log 2 (V5/GFP) − log 2 (V5(input)/GFP(input)).
Generation of mouse CIP-ASCL1 ESCs. Genome engineering of mouse ESCs was performed using the CRISPR/Cas9 protocol previously described 67 . Briefly, a repair template plasmid containing the modified Ascl1 locus was generated with 1-kb flanking homology arms. Two distinct DNA-binding sequence arrays were added 278 bp upstream of the TSS of Ascl1, 12× ZFHD1 elements (5′-TAATGATGGGCG-3′) and 5× Gal4 elements (5′-CGGAGTACTGTCCTCCGAG-3′). A sequence encoding nuclear EGFP was inserted at the ATG of exon 1 of Ascl1 to differentiate the edited allele. Two guide RNA sequences (sg1, 5′-AATAAACAGGCCGCGCGCTCGGG-3′; sg2, 5′-TGCCGGGCCAAACTGTCGCGGGG-3′) were cloned into the Cas9-2A-Puro plasmid obtained from the laboratory of F. Zhang (Massachusetts Institute of Technology).
Chemical induction of proximity on chromatin. The CIP assay was performed as previously described 44 . CIP-ASCL1 mESCs were transduced with lentivirus expressing ZFHD1 fused directly to the FKBP anchor and SS18 fused to two tandem repeats of FRB. Proximity was induced by addition of rapamycin at 30 nM (final concentration) for 0, 5, 15, or 60 min before collection for ChIP-qPCR.
Quantification of chromatin factors by ChIP-qPCR. ChIP was performed as described previously 44 , and qPCR samples were prepared using the SensiFAST SYBR Lo-Rox kit (Bioline, BIO-94020), according to the manufacturer's instructions. Analysis of qPCR samples was performed on a QuantStudio 6 Flex system (Life Technologies). The antibodies used for ChIP are listed in Supplementary Table 1. The sequences of the primers used are provided in Supplementary Table 3. Statistics. All differential calls for genomic data sets (ChIP-seq and RNA-seq) were made using DESeq2, where P values are calculated using the Wald test, as described in the DESeq2 documentation 56 . FDR-corrected P values were calculated using the Benjamini-Hochberg procedure. For presentation in heat maps, RNA-seq and ChIP-seq data were grouped using k-means clustering into k = 3 groups. Analysis of correlation was performed using the Pearson correlation test. All Student's t tests were performed as two-sided tests. Fisher's exact tests were performed as two-sided tests. Two-sample Kolmogorov-Smirnov tests were performed as two-sided tests. To validate the effects of SMARCA4 disruption using ChIP-qPCR data, qPCR enrichment values were compared for each primer set across antibodies and SMARCA4 conditions using one-way ANOVA as a two-sided test. All of the above statistical tests were performed using R. The hypergeometric test for over-representation was performed as a one-sided test using HOMER 61 .
Lasso multivariate regression. Lasso multivariate regression 38 n n … At each RING1B peak, the number of reads within ±3 kb of the center of the peak was summed for each of 111 features, using data from previously published data sets. The summed read count at each site was log 10 transformed and scaled to unit variance across all sites (x i ). Lasso regression was performed using the 'glmnet' R package 68 Data availability. The data sets generated in this study have been deposited in the GEO repository under accession GSE88968. Source data for Figures 1-4 are available online.
